Rémi Soula
No más puestos en curso
Fortuna: 3 M $ al 31/03/2024
Perfil
Rémi Soula was the founder and had founded Adocia SA in 2005 where he held the title of Director-Business Development from 2012 to 2019.
He has also held former positions as an Independent Non-Executive Director at Cellnovo Group SA, Director at Cellnovo Ltd., and Senior Manager at Flamel Technologies SA. Dr. Soula's education includes an MBA from École des Hautes Études Commerciales de Paris and a doctorate from École Supérieure de Chimie Physique Électronique.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADOCIA SA
1.98% | 31/12/2022 | 278 690 ( 1.98% ) | 3 M $ | 31/03/2024 |
Antiguos cargos conocidos de Rémi Soula.
| Empresas | Cargo | Fin |
|---|---|---|
| ADOCIA | Founder | 01/10/2019 |
Cellnovo Ltd.
 Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Director/Board Member | - |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Corporate Officer/Principal | - |
| CELLNOVO | Director/Board Member | - |
Formación de Rémi Soula.
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| École Supérieure de Chimie Physique Électronique | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ADOCIA | Health Technology |
| Empresas privadas | 3 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
- Bolsa de valores
- Insiders
- Rémi Soula
